Literature DB >> 2386045

A prospective incidence study of febrile convulsions.

L Forsgren1, R Sidenvall, H K Blomquist, J Heijbel.   

Abstract

A prospective epidemiological study of febrile convulsions (FC) was performed during a 20-month period. 128 children with FCs were identified. The annual first attendance rate and annual incidence rate were 500/100,000 and 460/100,000 respectively, in the age group 0-4 years. The cumulative incidence was 4.1%. FCs were more common among boys, with a male to female ratio of 1.72 to 1. The median and mean age for first FC was for boys 16 and 19.9 months respectively, and for girls 18 and 19.7 months respectively. During an average follow-up period of 20 months, 18% had another FC and 10% had two or more FCs. 8.6% had an initial complicated FC. Four children had FCs within two weeks after being vaccinated by combined vaccine against morbilli, rubella and parotitis. Three of these had earlier had an FC.

Entities:  

Mesh:

Year:  1990        PMID: 2386045     DOI: 10.1111/j.1651-2227.1990.tb11510.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  17 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Evaluation of Risk Factors Associated with First Episode Febrile Seizure.

Authors:  Indar Kumar Sharawat; Jitender Singh; Lesa Dawman; Amitabh Singh
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 3.  Do seizures damage the brain? The epidemiological evidence.

Authors:  C M Verity
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Distribution of febrile seizure duration and associations with development.

Authors:  Dale C Hesdorffer; Emma K T Benn; Emilia Bagiella; Douglas Nordli; John Pellock; Veronica Hinton; Shlomo Shinnar
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

5.  Snotwatch: an ecological analysis of the relationship between febrile seizures and respiratory virus activity.

Authors:  Rana Sawires; Martin Kuldorff; Michael Fahey; Hazel Clothier; Jim Buttery
Journal:  BMC Pediatr       Date:  2022-06-22       Impact factor: 2.567

6.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Authors:  Steven Black; Juhani Eskola; Claire-Anne Siegrist; Neal Halsey; Noni MacDonald; Barbara Law; Elizabeth Miller; Nick Andrews; Julia Stowe; Daniel Salmon; Kirsten Vannice; Hector S Izurieta; Aysha Akhtar; Mike Gold; Gabriel Oselka; Patrick Zuber; Dina Pfeifer; Claudia Vellozzi
Journal:  Lancet       Date:  2009-10-31       Impact factor: 79.321

Review 7.  Febrile seizures: an update.

Authors:  C Waruiru; R Appleton
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

8.  A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.

Authors:  Gary S Marshall; Shelly D Senders; Julie Shepard; Jerry D Twiggs; Julie Gardner; Darcy Hille; Jonathan Hartzel; Rowan Valenzuela; Jon E Stek; Frans A Helmond
Journal:  Hum Vaccin Immunother       Date:  2016-05-05       Impact factor: 3.452

9.  Family history and recurrence of febrile seizures.

Authors:  A van Esch; E W Steyerberg; M Y Berger; M Offringa; G Derksen-Lubsen; J D Habbema
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

10.  Birth characteristics and risk of febrile seizures.

Authors:  Kirstine J Christensen; Julie W Dreier; Line Skotte; Bjarke Feenstra; Jakob Grove; Anders Børglum; Mitja Mitrovic; Chris Cotsapas; Jakob Christensen
Journal:  Acta Neurol Scand       Date:  2021-04-06       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.